Mitochondrion- and endoplasmic reticulum-induced sk channel dysregulation as a potential origin of the selective neurodegeneration in parkinson’s disease

Systems Biology of Parkinson's Disease

Volumn , Issue , 2012, Pages 57-79

  Drion, Guillaume ^a   Seutin, Vincent ^a   Sepulchre, Rodolphe ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868034304     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-3411-5_4     Document Type: Chapter

References (82)

1. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson’s disease. Lancet 1:1267
2. Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson’s disease. J Neurochem 55:2142-2145
3. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AH, Marsden CD (1992) Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson’s disease. Brain 115:333-342
4. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson’s disease. Biochem Biophys Res Commun 163:1450-1455
5. Parker WD Jr, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson’s disease. Ann Neurol 26:719-723
6. Bindoff LA, Birch-Machin M, Cartlidge NE, Parker WD Jr, Turnbull DM (1989) Mitochondrial function in Parkinson’s disease. Lancet 2:49
7. Abou-Sleiman PM, Muqit MM, Wood NW (2006) Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Nat Rev Neurosci 7:207-219
8. Schapira AH (2008) Mitochondria in the aetiology and pathogenesis of Parkinson’s disease. Lancet Neurol 7:97-109
9. Sterky FH, Lee S, Wibom R, Olson L, Larsson NG (2011) Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci U S A 108:12937-12942
10. Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, Surmeier DJ (2010) Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468:676-680
11. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism-selective destruction of dopaminergic-neurons in the pars compacta of the substantia nigra by n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546-4550
12. Javitch JA, D’Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci U S A 82:2173-2177
13. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci 3:1301-1306
14. Dawson TM, Ko HS, Dawson VL (2010) Genetic animal models of Parkinson’s disease. Neuron 64:646-661
15. Bezard E, Przedborski S (2011) A tale on animal models of Parkinson’s disease. Mov Disord 26:993-1002
16. Martinez TN, Greenamyre JT (2012) Toxin models of mitochondrial dysfunction in Parkinson’s disease. Antioxid Redox Signal. 16:920-934
17. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2002) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197-211
18. Braak H, de Vos RA, Bohl J, Del Tredici K (2005) Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease- related brain pathology. Neurosci Lett 396:67-72
19. Obeso JA, Rodriguez-Oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, Marin C, Rodriguez M (2008) Functional organization of the basal ganglia: therapeutic implications for Parkinson’s disease. Mov Disord 23(Suppl 3):S548-S559
20. Fearnley JM, Lees AJ (1991) Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 114:2283-2301
21. Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, Halliday G (2010) Missing pieces in the Parkinson’s disease puzzle. Nat Med 16:653-661
22. Liss B, Haeckel O, Wildmann J, Miki T, Seino S, Roeper J (2005) K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci 8:1742-1751
23. Lu L, Neff F, Fischer DA, Henze C, Hirsch EC, Oertel WH, Schlegel J, Hartmann A (2006) Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson’s disease: a post-mortem study in human control subjects. Neurobiol Dis 23:409-421
24. Gonzalez-Hernandez T, Afonso-Oramas D, Cruz-Muros I (2009) Phenotype, compartmental organization and differential vulnerability of nigral dopaminergic neurons. J Neural Transm Suppl 73:21-37
25. Gonzalez-Hernandez T, Cruz-Muros I, Afonso-Oramas D, Salas-Hernandez J, Castro- Hernandez J (2010) Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease. Front Neuroanat 4:140
26. Surmeier DJ (2007) Calcium, ageing, and neuronal vulnerability in Parkinson’s disease. Lancet Neurol 6:933-938
27. Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, Meredith GE, Surmeier DJ (2007) ‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease. Nature 447:1081-1086
28. Guzman JN, Sanchez-Padilla J, Chan CS, Surmeier DJ (2009) Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci 29:11011-11019
29. Chan CS, Gertler TS, Surmeier DJ (2009) Calcium homeostasis, selective vulnerability and Parkinson’s disease. Trends Neurosci 32:249-256
30. Chan CS, Gertler TS, Surmeier DJ (2010) A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson’s disease. Mov Disord 25(Suppl 1): S63-S68
31. Surmeier DJ, Guzman JN, Sanchez-Padilla J (2010) Calcium, cellular aging, and selective neuronal vulnerability in Parkinson’s disease. Cell Calcium 47:175-182
32. Surmeier DJ, Guzman JN, Sanchez-Padilla J, Goldberg JA (2010) What causes the death of dopaminergic neurons in Parkinson’s disease? Prog Brain Res 183:59-77
33. Ilijic E, Guzman JN, Surmeier DJ (2011) The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson’s disease. Neurobiol Dis 43:364-369
34. Cali T, Ottolini D, Brini M (2011) Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson’s disease. Biofactors 37:228-240
35. Yuan Y, Cao P, Smith MA, Kramp K, Huang Y, Hisamoto N, Matsumoto K, Hatzoglou M, Jin H, Feng Z (2011) Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans. PLoS One 6(8):e22354
36. Wang HQ, Takahashi R (2007) Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson’s disease. Antioxid Redox Signal 9:553-561
37. Arduino DM, Esteves AR, Cardoso SM, Oliveira CR (2009) Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson’s disease. Neurochem Int 55:341-348
38. Grace AA, Bunney BS (1984) The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 4:2864-2876
39. Brazhnik E, Shah F, Tepper JM (2008) GABAergic afferents activate both GABAA and GABAB receptors in mouse substantia nigra dopaminergic neurons in vivo. J Neurosci 28:10386-10398
40. Puopolo M, Raviola E, Bean BP (2007) Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons. J Neurosci 27:645-656
41. Putzier I, Kullmann PH, Horn JP, Levitan ES (2009) Cav1.3 channel voltage dependence, not Ca2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons. J Neurosci 29:15414-15419
42. Grace AA, Bunney BS (1984) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877-2890
43. Schumacher MA, Rivard AF, Bachinger HP, Adelman JP (2001) Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin. Nature 410:1120-1124
44. Maylie J, Bond CT, Herson PS, Lee WS, Adelman JP (2004) Small conductance Ca2+-activated K+ channels and calmodulin. J Physiol 554:255-261
45. Kohler M, Hirschberg B, Bond CT, Kinzie JM, Marrion NV, Maylie J, Adelman JP (1996) Small-conductance, calcium-activated potassium channels from mammalian brain. Science 273:1709-1714
46. Vogalis F, Storm JF, Lancaster B (2003) SK channels and the varieties of slow afterhyperpolarizations in neurons. Eur J Neurosci 18:3155-3164
47. Ngo-Anh TJ, Bloodgood BL, Lin M, Sabatini BL, Maylie J, Adelman JP (2005) SK channels and NMDA receptors form a Ca2+-mediated feedback loop in dendritic spines. Nat Neurosci 8:550
48. Shepard PD, Bunney BS (1988) Effect of apamin on the discharge properties of putative dopamine-containing neurons in vitro. Brain Res 463:380-384
49. Shepard PD, Bunney BS (1991) Repetitive firing properties of putative dopamine-containing neurons in vitro: regulation by an apamin-sensitive Ca2+-activated K+ conductance. Exp Brain Res 86:141-150
50. Nedergaard S, Flatman JA, Engberg I (1993) Nifedipine- and omegaconotoxin-sensitive Ca2+ conductances in guinea-pig substantia nigra pars compacta neurones. J Physiol 464:707-747
51. Seutin V, Johnson SW, North RA (1993) Apamin increases NMDA-induced burst firing of rat mesencephalic dopamine neurons. Brain Res 630:341-344
52. Waroux O, Massotte L, Alleva L, Graulich A, Thomas E, Liegeois JF, Scuvee-Moreau J, Seutin V (2005) SK channel control the firing pattern of midbrain dopaminergic neurons in vivo. Eur J Neurosci 22:3111-3121
53. Ji H, Hougaard C, Herrik KF, Str0baek D, Christophersen P, Shepard PD (2009) Tuning the excitability of midbrain dopamine neurons by modulating the Ca2+ sensitivity of SK channels. Eur J Neurosci 29:1883-1895
54. Herrik KF, Christophersen P, Shepard PD (2010) Pharmacological modulation of the gating properties of small conductance Ca2+-activated K+ channels alters the firing pattern of dopamine neurons in vivo. J Neurophysiol 104:1706-1735
55. Drion G, Massotte L, Sepulchre R, Seutin V (2010) How modeling can reconcile apparently discrepant experimental results: the case of dopaminergic neurons. PLoS Comput Biol 7(5):e1002050
56. Hodgkin AL, Huxley AF (1952) A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol 117:500-544
57. Sejnowski TJ, Koch C, Churchland PS (1988) Computational neuroscience. Science 241:1299-1306
58. Hille B (2001) Ion channels of excitable membranes. Sinauer, Sunderland, MA, pp 95-129
59. Wolfart J, Neuhoff H, Franz O, Roeper J (2001) Differential expression of the small- conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J Neurosci 21:3443-3456
60. Izhikevich EM (2007) Dynamical systems in neuroscience: the geometry of excitability and bursting. The MIT, Cambridge, MA, pp 325-378
61. Noble D (1984) The surprising heart: a review of recent progress in cardiac electrophysiology. J Physiol 353:1-50
62. Noma A (1996) Ionic mechanisms of the cardiac pacemaker potential. Jpn Heart J 37:653-682
63. Blythe SN, Wokosin D, Atherton JF, Bevan MD (2009) Cellular mechanisms underlying burst firing in substantia nigra dopamine neurons. J Neurosci 29:15531-15541
64. Lobb CJ, Wilson CJ, Paladini CA (2010) A dynamic role for GABA receptors on the firing pattern of midbrain dopaminergic neurons. J Neurophysiol 104:403-413
65. Magee JC, Johnston D (1995) Synaptic activation of voltage-gated channels in the dendrites of hippocampal pyramidal neurons. Science 268:301-304
66. Sarpal D, Koenig JI, Adelman JP, Brady D, Prendeville LC, Shepard PD (2004) Regional distribution of SK3 mRNA-containing neurons in the adult and adolescent rat ventral midbrain and their relationship to dopamine-containing cells. Synapse 53:104-113
67. Bishop MW, Chakraborty S, Matthews GA, Dougalis A, Wood NW, Festenstein R, Ungless MA (2010) Hyperexcitable substantia nigra dopamine neurons in PINK1- and HtrA2/Omi- deficient mice. J Neurophysiol 104:3009-3020
68. Yanovsky Y, Zhang W, Misgeld U (2005) Two pathways for the activation of small- conductance potassium channels in neurons of substantia nigra pars reticulata. Neuroscience 136:1027-1036
69. Stocker M (2004) Ca(2+)-activated K+ channels: molecular determinants and function of the SK family. Nat Rev Neurosci 5:758-768
70. Scuvee-Moreau J, Waroux O, Alleva L, Boland A, Graulich A, Liegeois JF, SeutinV (2005) T-type calcium channels do not play a major role in the activation of SK channels in rat midbrain dopaminergic neurons. Program No. 376.13. 2005 Neuroscience Meeting Planner. Society for Neuroscience, Washington, DC, 2005. Online
71. Friel D (2004) Interplay between ER Ca2+ uptake and release fluxes in neurons and its impact on [Ca2+] dynamics. Biol Res 37:645-674
72. Coulon P, Herr D, Kanyshkova T, Meuth P, Budde T, Pape HC (2009) Burst discharges in neurons of the thalamic reticular nucleus are shaped by calcium-induced calcium release. Cell Calcium 46:333-346
73. Lee KH, Cho JH, Choi IS, Park HM, Lee MG, Choi BJ, Jang IS (2010) Pregnenolone sulfate enhances spontaneous glutamate release by inducing presynaptic Ca2+-induced Ca2+ release. Neuroscience 169:106-116
74. Barsukova AG, Bourdette D, Forte M (2011) Mitochondrial calcium and its regulation in neurodegeneration induced by oxidative stress. Eur J Neurosci 34:437-447
75. Steigerwald F, Potter M, Herzog J, Pinsker M, Kopper F, Mehdorn H, Deuschl G, Volkmann J (2008) Neuronal activity of the human subthalamic nucleus in the parkinsonian and nonparkinsonian state. J Neurophysiol 100:2515-2524
76. Duda JE (2009) Olfactory system pathology as a model of Lewy neurodegenerative disease. J Neurol Sci 289:49-54
77. Huot P, Fox SH, Brotchie JM (2011) The serotonergic system in Parkinson’s disease. Prog Neurobiol 95(2):163-212
78. Hallworth NE, Wilson CJ, Bevan MD (2003) Apamin-sensitive small conductance calcium- activated potassium channels, through their selective coupling to voltage-gated calcium channels, are critical determinants of the precision, pace, and pattern of action potential generation in rat subthalamic nucleus neurons in vitro. J Neurosci 23:7525-7542
79. Maher BJ, Westbrook GL (2005) SK channel regulation of dendritic excitability and dendrodendritic inhibition in the olfactory bulb. J Neurophysiol 94:3743-3750
80. Rouchet N, Waroux O, Lamy C, Massotte L, Scuvee-Moreau J, Liegeois JF, Seutin V (2008) SK channel blockade promotes burst firing in dorsal raphe serotonergic neurons. Eur J Neurosci 28:1108-1115
81. Sah P, McLachlan EM (1992) Potassium currents contributing to action potential repolarization and the afterhyperpolarization in rat vagal motoneurons. J Neurophysiol 68:1834-1841
82. Fujita A, Takeuchi T, Saitoh N, Hanai J, Hata F (2001) Expression of Ca(2+)-activated K(+) channels, SK3, in the interstitial cells of Cajal in the gastrointestinal tract. Am J Physiol Cell Physiol 281:C1727-C1733